These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23162126)

  • 1. A converse 4-1BB and CD40 ligand expression pattern delineates activated regulatory T cells (Treg) and conventional T cells enabling direct isolation of alloantigen-reactive natural Foxp3+ Treg.
    Schoenbrunn A; Frentsch M; Kohler S; Keye J; Dooms H; Moewes B; Dong J; Loddenkemper C; Sieper J; Wu P; Romagnani C; Matzmohr N; Thiel A
    J Immunol; 2012 Dec; 189(12):5985-94. PubMed ID: 23162126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD.
    Koenecke C; Czeloth N; Bubke A; Schmitz S; Kissenpfennig A; Malissen B; Huehn J; Ganser A; Förster R; Prinz I
    Eur J Immunol; 2009 Nov; 39(11):3091-6. PubMed ID: 19750478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.
    Plain KM; Verma ND; Tran GT; Nomura M; Boyd R; Robinson CM; Hodgkinson SJ; Hall BM
    Transpl Immunol; 2013 Dec; 29(1-4):51-9. PubMed ID: 24139939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-γ production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease.
    Koenecke C; Lee CW; Thamm K; Föhse L; Schafferus M; Mittrücker HW; Floess S; Huehn J; Ganser A; Förster R; Prinz I
    J Immunol; 2012 Sep; 189(6):2890-6. PubMed ID: 22869903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient induction and expansion of human alloantigen-specific CD8 regulatory T cells from naive precursors by CD40-activated B cells.
    Zheng J; Liu Y; Qin G; Chan PL; Mao H; Lam KT; Lewis DB; Lau YL; Tu W
    J Immunol; 2009 Sep; 183(6):3742-50. PubMed ID: 19684082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide.
    Pozo D; Anderson P; Gonzalez-Rey E
    J Immunol; 2009 Oct; 183(7):4346-59. PubMed ID: 19734220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased CD127 expression on activated FOXP3+CD4+ regulatory T cells.
    Simonetta F; Chiali A; Cordier C; Urrutia A; Girault I; Bloquet S; Tanchot C; Bourgeois C
    Eur J Immunol; 2010 Sep; 40(9):2528-38. PubMed ID: 20690182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor reactive regulatory T cells.
    Feng G; Chan T; Wood KJ; Bushell A
    Curr Opin Organ Transplant; 2009 Aug; 14(4):432-8. PubMed ID: 19448539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
    Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
    Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of circulating human antigen-reactive CD4+ FOXP3+ natural regulatory T cells.
    Litjens NH; Boer K; Betjes MG
    J Immunol; 2012 Feb; 188(3):1083-90. PubMed ID: 22190183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin enhances CD4(+) T-cell immune responses by inducing expression of CD40 ligand and 4-1BB.
    Park JY; Jang MJ; Chung YH; Kim KY; Kim SS; Lee WB; You S; Choi YS; Hur DY; Kim D
    Int Immunopharmacol; 2009 Dec; 9(13-14):1530-9. PubMed ID: 19778641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting regulatory T cells in type 1 diabetes.
    Zhang Y; Bandala-Sanchez E; Harrison LC
    Curr Opin Endocrinol Diabetes Obes; 2012 Aug; 19(4):271-8. PubMed ID: 22732485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation.
    Hoffmann P; Boeld TJ; Eder R; Huehn J; Floess S; Wieczorek G; Olek S; Dietmaier W; Andreesen R; Edinger M
    Eur J Immunol; 2009 Apr; 39(4):1088-97. PubMed ID: 19283780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonistic anti-4-1BB antibody promotes the expansion of natural regulatory T cells while maintaining Foxp3 expression.
    Zhang P; Gao F; Wang Q; Wang X; Zhu F; Ma C; Sun W; Zhang L
    Scand J Immunol; 2007 Oct; 66(4):435-40. PubMed ID: 17850588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of induced and natural FoxP3(+) regulatory T cells for the treatment of Graft-versus-host disease.
    Prinz I; Koenecke C
    Arch Immunol Ther Exp (Warsz); 2012 Jun; 60(3):183-90. PubMed ID: 22476537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of induced versus natural regulatory T cells of the same TCR specificity for induction of tolerance to an environmental antigen.
    Huang H; Ma Y; Dawicki W; Zhang X; Gordon JR
    J Immunol; 2013 Aug; 191(3):1136-43. PubMed ID: 23817420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of immunosuppressants on the therapeutic efficacy of in vitro-expanded CD4+CD25+Foxp3+ regulatory T cells in allotransplantation.
    Lim DG; Koo SK; Park YH; Kim Y; Kim HM; Park CS; Kim SC; Han DJ
    Transplantation; 2010 Apr; 89(8):928-36. PubMed ID: 20305583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human treg cells are characterized by low/negative CD6 expression.
    Garcia Santana CA; Tung JW; Gulnik S
    Cytometry A; 2014 Oct; 85(10):901-8. PubMed ID: 25088497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
    Giorgini A; Noble A
    J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.